CLGNのニュース
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs 2023/04/04 12:26:00 Business Wire
EDEN PRAIRIE, Minn. & REHOVOT, Israel--(BUSINESS WIRE)---- $SSYS #3dprinting--Stratasys Ltd. (Nasdaq: SSYS) and CollPlant Biotechnologies (Nasdaq: CLGN) today announced a joint development and commercialization agreement to collaborate on the development of a solution to bio-fabricate human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks. The first project focuses on the development of an industrial-scale solution for CollPlant''s regenerative breast implan
CollPlant GAAP EPS of -$1.53 beats by $0.03, revenue of $0.3M in-line 2023/03/29 11:06:15 Seeking Alpha
CollPlant press release (CLGN): FY GAAP EPS of -$1.53 beats by $0.03.Revenue of $0.3M (-98.1% Y/Y) in-line.Cash, cash equivalents and short-term deposits as of December 31,…
CollPlant (CLGN) Stock: Expanding End-Market Opportunities 2023/02/12 11:31:27 Seeking Alpha
CollPlant Biotechnologies is a unique biotech company anchored with AbbVie relationship. Click here to read my analysis of CLGN stock.
CollPlant Issues Letter to Shareholders 2023/01/24 12:00:00 PR Newswire
REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, is pleased to issue the following letter from its Chief Executive…
Can you now get a good deal on CollPlant Biotechnologies Ltd.’s shares? 2022/12/26 17:16:00 US Post News
The share price of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) fell to $8.34 per share on Friday from $8.68. While CollPlant Biotechnologies Ltd. has underperformed by -3.92%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLGN fell by -36.91%, with highs and lows ranging from $18.30 to $4.27, […]
CollPlant GAAP EPS of -$1.53 beats by $0.03, revenue of $0.3M in-line 2023/03/29 11:06:15 Seeking Alpha
CollPlant press release (CLGN): FY GAAP EPS of -$1.53 beats by $0.03.Revenue of $0.3M (-98.1% Y/Y) in-line.Cash, cash equivalents and short-term deposits as of December 31,…
CollPlant (CLGN) Stock: Expanding End-Market Opportunities 2023/02/12 11:31:27 Seeking Alpha
CollPlant Biotechnologies is a unique biotech company anchored with AbbVie relationship. Click here to read my analysis of CLGN stock.
CollPlant Issues Letter to Shareholders 2023/01/24 12:00:00 PR Newswire
REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, is pleased to issue the following letter from its Chief Executive…
Can you now get a good deal on CollPlant Biotechnologies Ltd.’s shares? 2022/12/26 17:16:00 US Post News
The share price of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) fell to $8.34 per share on Friday from $8.68. While CollPlant Biotechnologies Ltd. has underperformed by -3.92%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLGN fell by -36.91%, with highs and lows ranging from $18.30 to $4.27, […]
CollPlant Non-GAAP EPS of -$0.34, revenue of $0.11M 2022/12/01 12:27:55 Seeking Alpha
CollPlant press release (CLGN): Q3 Non-GAAP EPS of -$0.34.Revenue of $0.11M (-21.4% Y/Y).Cash, cash equivalents and short-term deposits as of September 30, 2022, were $33 million.
CollPlant Issues Letter to Shareholders 2023/01/24 12:00:00 PR Newswire
REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, is pleased to issue the following letter from its Chief Executive…
Can you now get a good deal on CollPlant Biotechnologies Ltd.’s shares? 2022/12/26 17:16:00 US Post News
The share price of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) fell to $8.34 per share on Friday from $8.68. While CollPlant Biotechnologies Ltd. has underperformed by -3.92%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLGN fell by -36.91%, with highs and lows ranging from $18.30 to $4.27, […]
CollPlant Non-GAAP EPS of -$0.34, revenue of $0.11M 2022/12/01 12:27:55 Seeking Alpha
CollPlant press release (CLGN): Q3 Non-GAAP EPS of -$0.34.Revenue of $0.11M (-21.4% Y/Y).Cash, cash equivalents and short-term deposits as of September 30, 2022, were $33 million.